Finance

Lists
CLGN:NASDAQ
Collplant Biotechnologies Ltd - ADR
USD 3,94
0,00%
(0,00) 1D
6 Nov., 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLGN...
Open
USD 4,18
High
USD 4,19
Low
USD 3,85
Mkt. cap
12,12 m
Avg. vol.
45,65 k
Volume
29,22 k
52-wk high
USD 22,50
52-wk low
USD 2,64
EPS
-USD 9,39
Beta
0,60
Shares outstanding
1,89 m
No. of employees
39
Open
USD 4,18
High
USD 4,19
Low
USD 3,85
Mkt. cap
12,12 m
Avg. vol.
45,65 k
Volume
29,22 k
52-wk high
USD 22,50
52-wk low
USD 2,64
EPS
-USD 9,39
Beta
0,60
Shares outstanding
1,89 m
No. of employees
39
News stories
From web sources and news partners
About Collplant Biotechnologies Ltd - ADR
CEO-
Employees39
Founded2004
Headquarters-
SectorHealth Care
Industry-
Websitecollplant.com
Analyst
Recommendation
Action
Price target
Projected
Date
Jason Kolbert
D. Boral Capital
Hold
Downgraded
-
-
02/06/2026
Previous reportsAll values in ILS
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
77,00 k
60,00 k
73,00 k
108,00 k
Cost of goods sold
269,00 k
192,00 k
316,00 k
564,00 k
Cost of revenue
269,00 k
192,00 k
316,00 k
564,00 k
Research and development expenses
2,09 m
1,98 m
1,68 m
1,16 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,23 m
1,04 m
1,19 m
1,01 m
Operating expense
3,32 m
3,02 m
2,87 m
2,18 m
Total operating expenses
3,58 m
3,21 m
3,19 m
2,74 m
Operating income
-3,51 m
-3,15 m
-3,12 m
-2,63 m
Other non operating income
-
-15,00 k
-
-
EBT including unusual items
-3,48 m
-3,21 m
-3,10 m
-2,73 m
EBT excluding unusual items
-3,48 m
-3,21 m
-3,10 m
-2,73 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,48 m
-3,21 m
-3,10 m
-2,73 m
Net profit margin
-4 523,38%
-5 345,00%
-4 242,47%
-2 524,07%
Earnings per share
-
-
-
-
Interest and investment income
24,00 k
329,00 k
18,00 k
-
Interest expense
-
-
-
-93,00 k
Net interest expenses
24,00 k
329,00 k
18,00 k
-93,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,28 m
-2,93 m
-2,90 m
-2,44 m
Gain or loss from assets sale
-
-
-
30,00 k
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme